Sunshine Biopharma Inc. Variable Lease, Cost
Sunshine Biopharma Inc. (SBFM) reported Variable Lease, Cost of $3.39 thousand for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-05-20.
Discontinued › Expense Statement › Operating Expenses
us-gaap:VariableLeaseCost · last filed 2019-05-20
- Sunshine Biopharma Inc. variable lease, cost for the quarter ending 2019-03-31 was $3.39K, a 74.99% decline year-over-year.
- Sunshine Biopharma Inc. variable lease, cost for the quarter ending 2018-03-31 was $13.55K.
| Period end | Variable Lease, Cost 3 month |
|---|---|
| 2019-03-31 | $3.39K 10-Q · filed 2019-05-20 |
| 2018-03-31 | $13.55K 10-Q · filed 2019-05-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |